Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 137

    1.

    Screening for diabetes: can we afford not to screen?

    Nathan DM, Herman WH.

    Ann Intern Med. 2004 May 4;140(9):756-8. No abstract available. PMID: 15126261 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. The cost-effectiveness of screening for type 2 diabetes.

    [No authors listed]

    Ann Intern Med. 2004 May 4;140(9):I29. No abstract available. PMID: 15126270 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Screening for diabetes in general practice. Population screening for diabetes is cost effective.

    Higson N.

    BMJ. 2002 Feb 16;324(7334):426. No abstract available. PMID: 11855395 [PubMed - indexed for MEDLINE]Related articles

    4.

    Screening for diabetes mellitus.

    Clement S, Duncan W, Coffey L, Dean K, Kinum N.

    Ann Intern Med. 1989 Apr 1;110(7):572-3. No abstract available. PMID: 2923391 [PubMed - indexed for MEDLINE]Related articles

    5.

    Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost--an epidemiologic review.

    Swanson M.

    Optometry. 2005 Nov;76(11):636-46. Review.PMID: 16298316 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cost-effectiveness of type 2 diabetes screening: results from recently published studies.

    Icks A, Rathmann W, Haastert B, John J, Löwel H, Holle R, Giani G; KORA Study Group.

    Gesundheitswesen. 2005 Aug;67 Suppl 1:S167-71.PMID: 16032536 [PubMed - indexed for MEDLINE]Related articles

    7.

    Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care.

    Feig DS, Palda VA, Lipscombe L; Canadian Task Force on Preventive Health Care.

    CMAJ. 2005 Jan 18;172(2):177-80. No abstract available. PMID: 15655234 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Finding undiagnosed type 2 diabetes: is it worth the effort?

    Engelgau MM, Narayan KM.

    Eff Clin Pract. 2001 Nov-Dec;4(6):281-3. No abstract available. PMID: 11769302 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Complications of diabetes: screening for retinopathy and management of foot ulcers.

    Melville A, Richardson R, McIntosh A, O'Keeffe C, Mason J, Peters J, Hutchinson A.

    Qual Health Care. 2000 Jun;9(2):137-41. No abstract available. PMID: 11067252 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    How frequently should patients with type 2 diabetes mellitus be screened for retinopathy?

    Murphy C, Newton W.

    J Fam Pract. 2000 May;49(5):395-6. No abstract available. PMID: 10836765 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.

    Hayashino Y, Shimbo T, Tsujii S, Ishii H, Kondo H, Nakamura T, Nagata-Kobayashi S, Fukui T.

    Int J Cardiol. 2007 May 16;118(1):88-96. Epub 2006 Sep 1.PMID: 16949690 [PubMed - indexed for MEDLINE]Related articles

    12.

    What determines the cost-effectiveness of diabetes screening?

    Glümer C, Yuyun M, Griffin S, Farewell D, Spiegelhalter D, Kinmonth AL, Wareham NJ.

    Diabetologia. 2006 Jul;49(7):1536-44. Epub 2006 Apr 26.PMID: 16752172 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Screening and intervention. A strategy in type 2 diabetes?]

    Jørgensen T, Glümer C, Borch-Johnsen K.

    Ugeskr Laeger. 2002 Apr 15;164(16):2135-9. Review. Danish. PMID: 11989055 [PubMed - indexed for MEDLINE]Related articles

    14.

    How often should patients with diabetes be screened for retinopathy?

    Hoskins HD Jr.

    JAMA. 2000 Jul 26;284(4):438-9. No abstract available. PMID: 10904497 [PubMed - indexed for MEDLINE]Related articles

    15.

    A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

    Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA.

    Nephrol Dial Transplant. 2008 Apr;23(4):1216-23.PMID: 18359872 [PubMed - indexed for MEDLINE]Related articles

    16.

    Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.

    Norris SL, Kansagara D, Bougatsos C, Fu R; U.S. Preventive Services Task Force.

    Ann Intern Med. 2008 Jun 3;148(11):855-68. Review.PMID: 18519931 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Screening for type 2 diabetes: literature review and economic modelling.

    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

    Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.PMID: 17462167 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Screening for type 2 diabetes mellitus in adults.

    Fink K, Clark B.

    Am Fam Physician. 2004 Feb 1;69(3):605-6. No abstract available. PMID: 14971844 [PubMed - indexed for MEDLINE]Related articles

    19.

    Preventing and detecting early vascular effects of diabetes: improvement must continue or costs will escalate.

    Kinshuck DJ.

    BMJ. 2006 Sep 16;333(7568):601-2. No abstract available. PMID: 16974019 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Summaries for patients. Screening adults for type 2 diabetes mellitus: recommendations from the U.S. Preventive Services Task Force.

    [No authors listed]

    Ann Intern Med. 2003 Feb 4;138(3):I-52. No abstract available. PMID: 12558380 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data